This week we’ll be attending the Healthcare Information and Management Systems Society (HIMSS) mega-conference in Las Vegas, and we hope to see you there! If you’re not familiar with it, HIMSS attracts more than 45,000 attendees and 1,300 exhibitors to share the latest developments and thinking about health information and technology. This meeting is so big that there are webinars and on-site orientation programs for first-time attendees. We don’t see that at our typical scientific meetings!
One of the reasons we’re interested in this meeting is that precision medicine is steadily increasing its presence there. For example, the precision medicine forum midway through the conference features some top-notch speakers and important topics for the community.
Among the highest-profile talks at HIMSS are the “View from the Top” sessions. This year, we’re looking forward to several of these presentations. Seema Verma from the Centers for Medicare and Medicaid Services will talk about the deployment of health IT for patients at her agency, while Google VP Gregory Moore will speak about the role of machine learning and cloud computing in healthcare in the future. Jan Kimpen, Chief Medical Officer of Philips, and David Higginson, CIO of Phoenix Children’s Hospital, will offer a joint chat about shifting responsibilities for CIOs as health systems aim to improve their success rates.
Here at QIAGEN’s bioinformatics group, we think a lot about the role of IT in healthcare. If you haven’t read it already, check out this forward-looking MLO column from our Chief Technology Officer, Ramon Felciano. “We will not fully embrace the era of genomic medicine without significant improvements to the computational infrastructure and policies that govern healthcare data,” he writes. “I believe that if we join forces and push for change, we can usher in a new era of clinical testing and significantly improved healthcare for patients around the world.”
The concept of precision medicine is beautifully simple: deliver the right treatment, every time, to the right patient. Making that concept a reality is more complex. Precision medicine is, after all, an entirely new approach to clinical medicine that leverages the power of big data and genomics to transform healthcare.
In a new on-demand webinar, Future of Genomics: The Precision Medicine Solution, our expert panel discusses how Aeon Global Health, the fastest growing clinical lab and healthcare services organization in the United States, partnered with QIAGEN to adopt an end-to-end automation solution that sped up their diagnostic output while lowering costs.
In 2013, when Aeon Global Health entered the hereditary cancer screening market, they knew that automation was critical to success. Together, QIAGEN Bioinformatics and Intel created a solution. By combining QIAGEN’s unparalleled expertise in genomics with Intel’s cutting-edge healthcare technology, the two companies enabled Aeon to provide faster, more comprehensive clinical insights than human cognition alone could permit. Today, one clinical geneticist at Aeon can process up to 50 tests per day.
Instead of taking weeks or months to make sense of a patient’s unique genetic profile, Aeon can now extract insights from colossal amounts of data in only a few minutes. And it’s not just the increase in efficiency that deserves attention. By partnering with Intel, QIAGEN has created an end-to-end solution that provides all workflow components, from analysis to interpretation to reporting, without having to hire hundreds of clinical geneticists and molecular pathologists, who would have to read reports and complete literature searches by hand. Clinical diagnostic test results are delivered quickly, accurately, and at a much lower cost.
As the amount of medical and biological data involved in medical diagnostics increases, so will the need for systems that help researchers, doctors and patients make sense of it. There are few medical advances as promising as precision medicine, and QIAGEN’s AI-based diagnostic tools—powered by Intel’s Scalable Solution Framework—are leading the way.
Join speakers Dr. Shawn Desai, Chief Technology Officer of Aeon Global Health, Dr. Ramon Felciano, Chief Technology Officer and Vice President of Strategy of QIAGEN Bioinformatics, and Kristina Kermanshahche, Global Director of Life Sciences at Intel Corporation, as they discuss how Aeon selected this powerful genomics solution and how you can build upon Aeon’s experience and accelerate your own path to success.
Watch Now — to learn how to put precision medicine on the fast track.
